KRAS and prostate carcinoma: K‐RAS transformation increases the level of GGT2 expression by activating the K‐RAS/ERK pathway.267 GGT2 expression in B1/K‐RAS cells contributes to resistance to H2O2 induced cell death. These results may facilitate the development of new anticancer therapies for K‐RAS oncogene‐induced cancers such as prostate cancer [42].